← Back to Search

Other

Reduced Nicotine Cigarettes for Tobacco Use Disorder

Q: Is this research undertaking presently looking for participants?

The data hosted on clinicaltrials.gov reveals that this research endeavour is actively in search of participants. It was first publicly posted on February 23rd 2022 and has been amended as recently as June 8th 2022.

Q: To what extent has this research study been populated with participants?

Affirmative. Records on clinicaltrials.gov demonstrate that this medical trial, which first started to accept participants on February 23rd 2022, is still actively recruiting patients. At the moment, there are 20 spots open at a single site for enrolment into the study.

Q: What other research endeavors have been conducted in regards to Reduced Nicotine Cigarettes?

At present, 71 Reduced Nicotine Cigarette studies are in progress. 5 of those trials have entered Phase 3 and 204 clinical sites across the country are running these experiments. Of special note is that many of these studies can be found near Greenville, <a href="https://www.withpower.com/clinical-trials/south-carolina">South carolina</a>.

Phase < 1

Waitlist Available

Led By Matthew Johnson

Research Sponsored by Johns Hopkins University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up four times over approximately two weeks

Awards & highlights

Study Summary

This trial is testing how different expectations and nicotine levels in cigarettes affects people's behavior and reaction to the cigarettes.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ post-cigarette administration four times over approximately two weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~post-cigarette administration four times over approximately two weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and post-cigarette administration four times over approximately two weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Demand Elasticity

Demand Intensity

Secondary outcome measures

Minnesota Nicotine Withdrawal Scale

Trial Design

4Treatment groups

Experimental Treatment

Group I: Reduced Nicotine Expectancy, Reduced Nicotine DoseExperimental Treatment2 Interventions

Receive reduced nicotine cigarette expecting reduced

Group II: Reduced Nicotine Expectancy, Full Nicotine DoseExperimental Treatment2 Interventions

Receive full nicotine cigarette expecting reduced

Group III: Full Nicotine Expectancy, Reduced Nicotine DoseExperimental Treatment2 Interventions

Receive reduced nicotine cigarette expecting full

Group IV: Full Nicotine Expectancy, Full Nicotine DoseExperimental Treatment2 Interventions

Receive full nicotine cigarette expecting full

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Very Low Nicotine Expectancy

2022

Completed Early Phase 1

~30

Average Nicotine Expectancy

2022

Completed Early Phase 1

~30

Full Nicotine Cigarettes

2022

Completed Early Phase 1

~30

Reduced Nicotine Cigarettes

2016

Completed Early Phase 1

~60

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor

2,260 Previous Clinical Trials

14,820,759 Total Patients Enrolled

17 Trials studying Tobacco Use Disorder

4,328 Patients Enrolled for Tobacco Use Disorder

National Institute on Drug Abuse (NIDA)NIH

2,467 Previous Clinical Trials

2,619,102 Total Patients Enrolled

271 Trials studying Tobacco Use Disorder

49,046 Patients Enrolled for Tobacco Use Disorder

Matthew JohnsonPrincipal InvestigatorJohns Hopkins School of Medicine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research undertaking presently looking for participants?

"The data hosted on clinicaltrials.gov reveals that this research endeavour is actively in search of participants. It was first publicly posted on February 23rd 2022 and has been amended as recently as June 8th 2022."

Answered by AI

To what extent has this research study been populated with participants?

"Affirmative. Records on clinicaltrials.gov demonstrate that this medical trial, which first started to accept participants on February 23rd 2022, is still actively recruiting patients. At the moment, there are 20 spots open at a single site for enrolment into the study."

Answered by AI

What other research endeavors have been conducted in regards to Reduced Nicotine Cigarettes?

"At present, 71 Reduced Nicotine Cigarette studies are in progress. 5 of those trials have entered Phase 3 and 204 clinical sites across the country are running these experiments. Of special note is that many of these studies can be found near Greenville, South carolina."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Reduced Nicotine Cigarette Purchasing Decisions

2022. "Reduced Nicotine Cigarette Purchasing Decisions". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04999644.